Norbuprenorphine

METABOLITES

This is a Controlled Substance.
For exact pricing and delivery please contact sales@clearsynth.com
Product Details

CAT No.# CS-T-57085
Category Metabolites
CAS 78715-23-8
Molecular Weight 413.55
Molecular Formula C25H35NO4
Stock Status: In-Stock
Purity: >98%
Solubility: Methanol
Appearance: Light Beige Solution
Synonyms: (1R,2R,6S,14S,15S,16R)-16-[(2R)-2-hydroxy-3,3- dimethylbutan-2-yl]-15-methoxy-13-oxa-3- azahen-11-ol
Application Notes: A metabolite of Buprenorphine .
References: Cone, E., et al.: Drug Metab. Dispos., 12, 577 (1984), Chauvin, M., et al.: Anesthesiology, 66, 327 (1987), Ceccato, A., et al.: J. Pharm. Biomed. Anal., 32, 619 (2003), Sittl, R., et al.: Clin. Ther., 27, 225 (2005),
Storage: -20°C Freezer
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. (6R,7S)-7-(2-chloroacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
2. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
3. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
4. Benidipine D7
5. Lauroside D
6. Triazolam 13C D3
7. Icatibant impurity 1
8. BISPHENOL AF (RING-13C12)
9. 0.1% TFA in Water ULC-MS
10. Metamizole EP Impurity C HCl
11. Silodosin Metabolite D4
12. Brivaracetam Carboxylic acid metabolite [UCB 42145]
13. Terbuthylazine D5
14. tibolone (848)
15. (Z)-Dimethylvinphos
16. Silodosin Metabolite
17. 2-Phenoxymethanesulfonanilide
18. Nimesulide EP Impurity A
19. Acetone HPLC
20. Nandrolone Decanoate EP impurity F


SMILES:
C[C@@](O)(C(C)(C)C)[C@H]1C[C@@]2([C@H]3CC4=CC=C(C5=C4[C@@]2(CCN3)[C@H]6O5)O)CC[C@@]16OC([2H])([2H])[2H]



This page contains information about Norbuprenorphine Cas 78715-23-8 and its Metabolites.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."